Corpus ID: 1076801

[Results of phase III study of lentinan].

@article{Taguchi1985ResultsOP,
  title={[Results of phase III study of lentinan].},
  author={T. Taguchi and H. Furue and T. Kimura and T. Kondo and T. Hattori and I. Itoh and N. Ogawa},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={1985},
  volume={12 2},
  pages={
          366-78
        }
}
  • T. Taguchi, H. Furue, +4 authors N. Ogawa
  • Published 1985
  • Medicine
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • A follow-up survey of survivals (Oct. 1 '80 to May 1, '84) in a randomized controlled study (Aug. '79 to Sept. 30' 80) of lentinan in combination administration with chemotherapeutic agents such as 5FU + mitomycin C or tegafur on patients with advanced or recurrent gastrointestinal cancer has shown that lentinan has been effective in such cases with regard to the following facts: 1) A life span prolongation effect at the end-point has been observed with statistical significance in lentinan… CONTINUE READING
    37 Citations
    Report on nationwide pooled data and cohort investigation in UFT phase II study
    • 53
    Chemotherapy for advanced gastric cancer.
    • 264
    Antitumor activity of a beta-1,3-glucan obtained from liquid cultured mycelium of Grifola frondosa.
    • 32
    Quantitative assay of lentinan in human blood with the limulus colorimetric test.
    • 9
    • PDF
    Immunomodulating activities of Sarcodon aspratus
    • PDF